Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.56 | N/A |
PEG Ratio (TTM) | -0.29 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 3.34 | N/A |
P/FCF Ratio (TTM) | -9.30 | N/A |
Price to 5YR AVG Earnings Ratio | -11.02 | N/A |
Price to 5YR AVG FCF Ratio | -22.48 | N/A |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -41.95% | N/A |
ROE (TTM) | -38.27% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | 1,018.90% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -24.05% | -367.60% | -235.93% |
Revenue | N/A | N/A | N/A |
Net Income | -17.36% | -124.64% | -96.94% |
Cash Flow | -9.42% | -133.28% | -97.79% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 19.08 | N/A |
Quick Ratio (TTM) | 19.08 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -8,797.98 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 36.54 | N/A |
LTL to 5YR AVG FCF | 0.00 | N/A |
Shares Outstanding Growth 5YR AVG | 93.78% | N/A |